SCHEMBL27848985

SCHEMBL27848985

CS(=O)(=O)NCC(C(N)=O)c1cccc(C(F)(F)F)c1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 8/20 0.46
PNMT P11086 1/20 0.45
MEN1 O00255 1/20 0.44
ALDH1A1 P00352 1/20 0.44
CYP1A2 P05177 1/20 0.44
POLB P06746 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
KMT2A Q03164 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
CES2 O00748 1/20 0.42
MMP7 P09237 1/20 0.41
KCNQ2 O43526 1/20 0.41
CHRM2 P08172 1/20 0.41
CHRM4 P08173 1/20 0.41
CHRM3 P20309 1/20 0.41
TRPM8 Q7Z2W7 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27848980 0.89 MEN1 (0.46) EPHX1PNMTMEN1ALDH1A1CYP1A2
SCHEMBL27849010 0.83 EPHX1 (0.48) EPHX1PNMTMEN1ALDH1A1CYP1A2
SCHEMBL10216797 0.82 PNMT (0.46) PNMTCYP1A2CYP3A4CES2MMP7
Hydrochloric Acid SCHEMBL382000 0.81 PNMT (0.44) EPHX1PNMTCYP1A2CYP3A4CES2
SCHEMBL23539801 0.80 CYP1A2 (0.56) EPHX1PNMTMEN1ALDH1A1CYP1A2
SCHEMBL3446920 0.79 KCNQ3 (0.44) PNMTMEN1ALDH1A1CYP1A2POLB
SCHEMBL27865909 0.78 PNMT (0.62) EPHX1PNMTMEN1ALDH1A1CYP1A2
SCHEMBL30699967 0.77 PNMT (0.53) EPHX1PNMTMEN1ALDH1A1CYP1A2
SCHEMBL30219768 0.77 PNMT (0.53) EPHX1PNMTMEN1ALDH1A1CYP1A2
SCHEMBL10216755 0.75 PTPRB (0.45) MEN1CYP1A2POLBCYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102438990-A Substituted 2-acetamido-5-aryl-1, 2, 4-triazolones and use thereof BAYER SCHERING PHARMA AG 2012-05-02 CN disclosed